Literature DB >> 7540351

Regulation of function and expression of P-selectin.

R P McEver1.   

Abstract

P-selectin is an adhesion receptor for leukocytes that is expressed on activated platelets and endothelial cells. The surface expression of P-selectin is tightly regulated through signals in the cytoplasmic domain that mediate sorting into secretory granules, internalization into coated pits, and targeting to lysosomes for degradation. Like the other selectins, P-selectin binds sialylated, fucosylated carbohydrate ligands such as sialyl Lewis x. However, it binds with much higher affinity to PSGL-1, a sialomucin-like glycoprotein on myeloid cells. Binding of PSGL-1 to P-selectin may be essential for leukocytes to roll on P-selectin-expressing cells under shear forces.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540351     DOI: 10.1007/978-3-0348-7343-7_10

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  10 in total

1.  Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin.

Authors:  Vandana S Dole; Wolfgang Bergmeier; Heather A Mitchell; Sarah C Eichenberger; Denisa D Wagner
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

2.  Identification of human complement Factor H as a ligand for L-selectin.

Authors:  R Malhotra; M Ward; R B Sim; M I Bird
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

3.  Radiation-guided P-selectin antibody targeted to lung cancer.

Authors:  G Hariri; Y Zhang; A Fu; Z Han; M Brechbiel; M N Tantawy; T E Peterson; R Mernaugh; D Hallahan
Journal:  Ann Biomed Eng       Date:  2008-02-14       Impact factor: 3.934

4.  Mucin AgC10 from Trypanosoma cruzi Interferes with L-selectin-mediated monocyte adhesion.

Authors:  Pilar Alcaide; Yaw Chin Lim; Francis W Luscinskas; Manuel Fresno
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

5.  First-in-Man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin.

Authors:  Christophe Schmitt; Markus Abt; Cornelia Ciorciaro; Dorothee Kling; Candice Jamois; Eginhard Schick; Corinne Solier; Renée Benghozi; Jacques Gaudreault
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

6.  Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit.

Authors:  Katrina K Ki; Margaret R Passmore; Chris H H Chan; Maximilian V Malfertheiner; Jonathon P Fanning; Mahé Bouquet; Jonathan E Millar; John F Fraser; Jacky Y Suen
Journal:  Intensive Care Med Exp       Date:  2019-08-20

Review 7.  Emerging Anti-Atherosclerotic Therapies.

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Magdalena Rysz-Górzyńska; Janusz Ławiński; Jacek Rysz
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

8.  Targeting of P-selectin to two regulated secretory organelles in PC12 cells.

Authors:  J P Norcott; R Solari; D F Cutler
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

Review 9.  Glycosaminoglycans analogs from marine invertebrates: structure, biological effects, and potential as new therapeutics.

Authors:  Mauro S G Pavão
Journal:  Front Cell Infect Microbiol       Date:  2014-09-10       Impact factor: 5.293

10.  Granulocyte-Derived Extracellular Vesicles Activate Monocytes and Are Associated With Mortality in Intensive Care Unit Patients.

Authors:  Ali Danesh; Heather C Inglis; Mohamed Abdel-Mohsen; Xutao Deng; Avril Adelman; Kenneth B Schechtman; John W Heitman; Ryan Vilardi; Avani Shah; Sheila M Keating; Mitchell J Cohen; Evan S Jacobs; Satish K Pillai; Jacques Lacroix; Philip C Spinella; Philip J Norris
Journal:  Front Immunol       Date:  2018-05-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.